STMN1 and ovarian cancer: On the other side, introducing miR-31 to TX-resistant ovarian cancer cells not only reduced STMN1 expression followed by restoring chemoresponse, but also gave many signs that indicate the functional absence of STMN1, including MT stability and promotion of cell cycle progression from G2 to M phase.